My Presentation of 3/11 Viral Takeover to Doctors for COVID Ethics
Sonia Elijah, an investigative journalist, presented her debut book *3/11 Viral Takeover*, a forensic examination of the COVID‑19 pandemic response. She detailed how a coordinated narrative—shaped by influential scientists and officials like Fauci, Collins, and the WHO—promoted lockdowns, rushed vaccine authorizations, and extensive censorship while suppressing alternative viewpoints such as the Great Barrington Declaration. The presentation highlighted key evidence from FOIA‑released emails, conflicted‑interest‑laden research papers, and flawed PCR testing protocols that underpinned public health policies. Elijah argues that fear was weaponized to expand state power, drawing parallels to post‑9/11 surveillance expansions.
Diagnosing the Future: Proteins, Biosensors and Fundamental Science with Prof. Eleonora Macchia
In this episode, Prof. Eleonora Macchia discusses how fundamental research on protein interactions can be turned into ultra‑sensitive biosensors for early disease detection, highlighting her ERC project that moved from studying topological transitions of proteins to a clinical trial for pancreatic...
EXCLUSIVE: Peptides, Fauci & MAHA - What You Need to Know | Daily Pulse
In this episode, host Maria Z interviews Dr. Lynn Finn, a retired infectious disease specialist turned clinical researcher, to unpack the rising popularity and risks of peptide supplements. Dr. Finn explains what peptides are, their potential therapeutic uses, and why...
Big Apple Exclusive: Dr. McCullough Goes Live to Unveil Potential Cancer Breakthrough
In this episode, Dr. Peter McCullough, chief scientific officer of a wellness company, discusses an observational report on the off‑label use of two generic drugs—ivermectin and mebendazole—in cancer patients. The study, now under peer review, found that nearly half of participants...
Mikey Adams Talks Radio, MaineCare Fraud and the Fight for Common Sense - MWTV
In this episode of MainWire TV, host Tom Shattuck chats with Boston‑Connecticut radio veteran Mikey Adams and MainWire editor Steve Robinson about the decline of free‑wheeling radio, past scandals like Adams’s 1994 cannabis bust, and the current wave of fraud...
WHO Blunder Imperils Remaining Passengers on Hantavirus-Infected Cruise Ship
In this episode, host Steve discusses a hantavirus outbreak aboard a cruise ship off the coast of Cape Verde, where passengers are confined to cabins while the virus spreads via rodent droppings and recirculated air. Dr. Peter McCullough, chief scientific officer...
MAHA Split Over New Surgeon General
In this episode of CareTalk, hosts David Williams and John Driscoll dissect the fallout from Casey Means' failed Surgeon General nomination and examine the administration’s pivot to Dr. Nicole "Sapphire" Sloan, a Fox News‑regular radiologist with an active medical license. They...
Remembering J. Craig Venter, PhD
In this tribute episode of Touching Base, host Corinna Singelman and Gen editors John Sterling and Kevin Davis reflect on the life and legacy of biotech pioneer J. Craig Venter, who recently died at 79. They recount Venter's groundbreaking role...
EP510: The Impact on You of Medicare Advantage Goings-On (2026 Edition), With Betsy Seals
In this episode, host Stacey Richter talks with Medicare Advantage expert Betsy Seals about the current stabilization phase of the MA market, highlighting profit versus profiteering, cost‑shifting to commercial employers, and the impact of vertical integration on provider payments. Seals...
What Impact Could Protein Stabilisation Have for Cancer Patients?
In this episode of the DDW Podcast, CEO Anthony Johnson and CSO Matthew Fyfe discuss OutRun Therapeutics' novel protein‑stabilisation platform, which inhibits specific E3 ubiquitin ligases to prevent degradation of disease‑relevant proteins. Their lead program targets the E6AP ligase to...
Live with Dr. Jen Gunter
In this episode, host Dr. Cammy Dahl chats with Dr. Jen Gunter about Gunter's new book, *A Terrible Strength*, which explores how systemic racism and the cultural expectation of endurance among Black women lead to delayed diagnosis and higher mortality...
University of Utah Health’s Kawamoto Says Workbench Approach Scales Clinical AI Across the Enterprise
Dr. Ken Kawamoto, University of Utah Health’s Chief Health AI Transformation Officer, discusses how his team is scaling clinical AI across the enterprise using a standards‑based AI Workbench that plugs into the Epic EHR. He explains the evolution of his...
431. ALCOHOL AT ANY DOSE CAUSES CANCER, VIOLENCE, AND SHRINKS YOUR BRAIN
The episode dismantles the myth that moderate alcohol consumption is safe, citing the 2018 Global Burden of Disease Study and subsequent research that show any level of drinking increases risk of cancer, brain atrophy, cardiovascular damage, and death. It details...
DDW Highlights: 6 May 2026
In this episode, Bruno Quinney highlights a surge in UK biotech financing, noting £552 million ($746 million) in Q1 2026 equity funding and the UK's capture of 57% of European biotech venture capital. He also covers the UK’s sweeping clinical‑trial reforms aimed at...
Why Healthcare Costs Keep Climbing
In this brief episode, Dr. Pearl discusses how generative AI can empower patients and clinicians by providing instant, personalized health insights before a doctor's visit, illustrated with a real‑world example of a skier diagnosing a rotator cuff tear via ChatGPT....
Addressing Treatment Gaps in Gout
In this episode, Crystallis Therapeutics CEO James McKay explains the biology of gout, why existing urate‑lowering drugs often fail, and how the company’s next‑generation URAT1 inhibitor, detenurad, aims to close the large treatment gap for moderate‑to‑severe patients. He highlights that...
GLP Podcast: ‘Safe Injection Sites’: Enabling Drug Addiction or Saving Lives?
In this episode of the Facts and Fallacies podcast, host Cameron English and medical toxicologist Dr. Liza Lockwood debate the merits of safe injection sites as a response to the U.S. opioid overdose crisis. They examine arguments that such facilities...
The AI Paradox: Why LLMs in Healthcare Actually Require More Structured Data, Not Less | Ewout Kramer & Ward Weistra...
In this episode, Awad Kramer and Ward Weistra of Firely discuss the origins and evolution of FHIR Dev Days, a community‑driven conference that educates developers on implementing the FHIR standard. They highlight how FHIR has become the backbone of health‑IT...
Beyond the Prescription Pad: A Empiric Path to Restoring Your Child's Focus and Calm
In this episode Dr. Todd Bourne, a naturopathic physician with 16 years of experience, discusses the rise of ADHD in children, its diagnostic criteria, and the limitations of medication as a long‑term solution. He highlights how modern environmental factors—especially excessive...
Mass General Brigham’s Sriraman Says SaaS Outages Expose Hidden Cloud Dependencies
In this episode of the Health System CIO Show, Mass General Brigham CTO Sri Sriraman discusses the hidden dependencies of SaaS applications on public cloud infrastructures, highlighting recent multi‑region outages that exposed a lack of transparency around where vendors host...
863: Developing Novel Materials with Wide Applications From Medicine to Manufacturing - Dr. Tim Long
In this episode, Dr. Tim Long, a chemistry professor and director of the Macromolecules Innovation Institute at Virginia Tech, discusses his research on designing novel macromolecular structures that impact fields ranging from chemotherapy to electroactive prosthetic devices. He emphasizes the...
Australia, How Do We Get Rid of AHPRA? Melinda Richards, Dr Paul Oosterhuis and MGG in the Cafe
In this episode, host and guests Melinda Richards and Dr. Paul Oosterhuis discuss the controversial role of Australia's health regulator AHPRA, arguing it has become a tool for political control rather than patient safety. They cite multiple doctors who were...
Redefining Success in Transplant Medicine
In this episode of Signals KOLs, transplant nephrologist Dr. Deirdre Sawinski, industry veteran Steve Risk (SVP Medical Affairs at Veloxys), and patient‑physician Sejal Patel discuss the stagnant long‑term outcomes in kidney transplantation despite excellent short‑term success. They highlight how current...
The Future of Cancer Treatment?
In this episode, host Lance interviews Dr. Peter McCullough about the potential of ivermectin and the related drug mebendazole as novel cancer therapies. McCullough cites pre‑clinical data and a real‑world observational study of about 200 patients, reporting that 84% experienced clinical...
Psychedelics in Medicine: Curiosity & Caution
In this episode, Dr. Ryan Cole and addiction specialist Dr. Molly Rutherford discuss the surge of interest in psychedelic‑assisted therapies for conditions like addiction, PTSD, and depression, highlighting the recent presidential executive order that accelerates FDA review and funding for these...
Dr. Kimberly Biss Speaks with Freedom Counsel
In this episode, Dr. Kimberly Biss discusses her observations of dramatically increased miscarriage rates among her patients following COVID‑19 vaccination, citing a rise from a normal 4‑5% to as high as 30% before rates began to normalize. She critiques social‑media...
The Cyborgs Commeth - EP 69 Connor Glass
In this episode, host Ashley Vance talks with Connor Glass, co‑founder and CEO of Phantom Neuro, about the company’s sub‑dermal neural interface that lets amputees control prosthetic limbs using muscle‑derived electrical signals—offering a less invasive alternative to brain‑computer interfaces like...
WATCH NOW: Prior Authorization: Care, Delayed | EP 3
In this episode of Healthcare Uncovered, the hosts examine the burdens of prior authorization on patients and clinicians, featuring Dr. Wendy Dean, co‑founder of Moral Injury of Healthcare, and former health‑system executive Dr. Seth Glickman. They discuss how prior‑auth requirements...
OpenAI’s Big Reset + A.I. in the Doctor’s Office + Talkie, a Pre-1930s LLM
In this episode of Hard Fork, hosts Kevin Roos and Casey Noon dissect OpenAI’s strategic overhaul, including a revised Microsoft partnership that removes the AGI revenue clause, a $50 billion investment and model‑hosting deal with Amazon’s Bedrock, and a shift away...
The Women’s Health Playbook
The Women’s Health Playbook podcast, hosted by Priya Bathija, breaks down the complexities of navigating U.S. healthcare for women, offering actionable strategies for every stage of a doctor’s visit—from choosing the right clinician to preparing for appointments and deciphering medical...
Will AI Help You Live 50 More Years? Immunologist Derya Unutmaz Weighs In
In this episode, NIH‑funded immunologist Derya Unutmaz discusses his bold predictions that AI will usher in a "biosingularity"—a convergence of artificial intelligence and biotechnology that could extend human lifespan by decades and automate half of white‑collar work within the next...
EXPLAINER: Medicine's Forgotten Biomarker - The Homocysteine Story Your Doctor Missed
In this episode Dr. Robert Lufkin explains why homocysteine, an amino‑acid by‑product of methionine metabolism, is a powerful but overlooked risk factor for heart disease, stroke, and dementia. He reviews the biological mechanisms by which elevated homocysteine damages arterial endothelium...
343. Summary: Can This Nutrient Help Alzheimer's? - Life Extension
In this episode, Dr. Mike and Dr. Crystal discuss a recent pilot study on creatine supplementation as a potential therapy for Alzheimer's disease, featuring insights from lead author Aaron Smith. They explain how creatine, known for its role in muscle...
“They Just Walked Away”: Maine Senate Kills Transparency Bill Amid DHHS Controversy - MWTV
The episode covers the heated fight over Maine’s LD‑127 transparency bill, which would let a bipartisan oversight committee access DHHS records on child welfare deaths. Host Tom Shattuck and panelists detail how the Senate rushed to adjourn and “sign‑die” the...
BREAKING: Senate Investigation Finds FDA Officials Covered-Up 25 COVID Shot Safety Signals
The episode examines a Senate investigation revealing that FDA officials allegedly suppressed about 25 statistically significant safety signals linked to COVID‑19 vaccine adverse events, including serious conditions such as Bell's palsy, cardiac failure, sudden cardiac death, and strokes. It details...
Could This Be the First Parkinson's Disease Modifier?
In this brief episode, the host and a GAIN representative discuss GT02287, a novel allosteric modulator targeting the glucocerebrosidase (GCase) enzyme, as a potential disease‑modifying therapy for Parkinson’s disease. They explain how the drug stabilizes the misfolded enzyme’s shape, enhancing...
Psychedelics for Mental Illness: Dr. Joseph Varon on Trump’s Executive Order
In this episode, Fox News discusses President Trump's new executive order aimed at loosening restrictions and expanding access to psychedelic therapies for severe mental health conditions such as depression, PTSD, and addiction, especially among veterans. Dr. Joseph Varon, president and...
Reducing Cardiovascular Risk: A Playbook for Lipid-Lowering Pharmacotherapy
The episode outlines a practical decision‑making framework for lipid‑lowering pharmacotherapy, emphasizing that the key question is not whether to treat high LDL‑C but how to choose the optimal therapy. It explains how to assess baseline labs, identify the dominant cholesterol...
AI-Powered Longevity Science — One Gene to Reverse Aging? | Daniel Ives PhD
In this episode, Dr. Robert Lovekin talks with Dr. Daniel Ives, founder of Shift Bioscience, about moving from hypothesis‑driven aging research to data‑driven, AI‑powered approaches. Ives explains how his early focus on mitochondrial DNA mutations as the primary cause of...
Dr. Oliver Kharraz on the Decades-Long Journey to Make Scheduling a Doctor's Appointment Easier
In this episode, Christina Farr talks with Oliver Kharraz, CEO of Zocdoc, about the 15‑year quest to simplify doctor appointment scheduling. Kharraz explains how hidden appointment inventory and last‑minute cancellations can be leveraged as a matchmaking clearinghouse, and recounts early...
The Longevity Economy Is Built for the Rich
The episode examines the $6 trillion "longevity economy"—the booming market built around anti‑aging and wellness innovations—and highlights how its benefits are disproportionately accessible to the wealthy. It outlines macro trends driving investment in longevity, critiques the uneven distribution of cutting‑edge therapies,...
The Deep State’s Medical Playbook
The episode critiques the Trump administration’s nomination of Navy doctor Erica Schwartz as CDC director, arguing she aligns with pro‑vaccine, “COVIDian” policies that threaten medical freedom. Guest Dr. Peter McCullough discusses alleged CIA suppression of Soviet research showing anti‑parasitic drugs like...
New Government Data Confirms Multiple Major Cancers Surged in Young Americans During the Mass mRNA Injection Campaign
The episode discusses newly released NIH National Cancer Institute data showing a 6.4% rise in overall cancer incidence among Americans under 50 between 2021 and 2023, with sharp increases in colorectal, brain, ovarian, small‑intestine, stomach, and breast cancers. Host and...
AI in Oncology Takes Off, Tackling HIV and Liver Disease, Pharma’s Recent Gains
The episode recaps highlights from the AACR conference, emphasizing that AI is moving from pre‑clinical research into clinical oncology, but adoption is hampered by low digital pathology uptake (under 10% of U.S. labs), trust issues, and infrastructure costs. It then...
426. The Case for Universal Vaginal Estrogen Use After Menopause
The episode explains why universal vaginal estrogen use after menopause is essential, detailing how systemic HRT fails to restore the vaginal and lower urinary tract tissues that suffer from genitourinary syndrome of menopause (GSM). Low‑dose vaginal estradiol—whether in compounded cream,...
Prior Authorization: Care, Delayed | EP 3
In this episode of Healthcare Uncovered, hosts Joe Rotino and Wendell Potter expose how prior authorization has become a pervasive barrier that delays critical care, inflates administrative costs, and contributes to patient harm, illustrated by the tragic death of a...
Episode 61 - GLP-1s, Biosimilars and Pharmacy Spend: Insights From Employers Health's Book of Business
In this episode, Employers Health’s analytics and clinical leaders, Jack Solomon and Hannah Weitzel, discuss how data‑driven strategies are shaping pharmacy spend, focusing on GLP‑1 weight‑loss drugs and autoimmune biologics. They reveal that about 60% of their client base now...
Dr George Fareed and Dr Paul Oosterhuis on the Breakthroughs with Turbo-Cancer Treatment
In this episode, Dr. George Fareed and Dr. Paul Oosterhuis discuss their "Turbo‑Cancer" protocol, a repurposed‑drug regimen originally developed for COVID‑19 that they claim has treated between 10,000 and 20,000 patients. They outline the core components—hydroxychloroquine, zinc, doxycycline or azithromycin,...
How AI and Robotics Designed New Cancer Therapies
In this episode, Angus Sinclair, CSO of LabGenius Therapeutics, explains how their AI‑driven AVA platform combines high‑throughput cell‑based assays with machine learning to design non‑intuitive protein therapeutics, specifically T‑cell engagers for solid tumors. He details the challenges of targeting antigens...
Lung Cancer Voices of Hope
In the inaugural episode of "Lung Cancer Voices of Hope," oncology nurse Anne Stegall and thoracic oncologist Dr. Misty Shields discuss the critical role of information, support, and community for patients and caregivers navigating a lung cancer diagnosis. They introduce...